期刊文献+

RNAi对B系淋巴瘤Namalwa细胞中VEGF表达和增殖的影响

Effect of RNA interference mediated VEGF gene silencing on Namalwa cell
下载PDF
导出
摘要 目的应用RNA干扰(RNA interference,RNAi)技术抑制VEGF的表达,观察其对B系淋巴瘤细胞株Namalwa生物学行为的影响。方法设计3条针对人VEGF mRNA的siRNA序列,经脂质体转染至Namalwa细胞。采用RT-PCR、Western blot法检测转染后Namalwa细胞VEGF mRNA和蛋白的表达。结果 siRNA-2组VEGF mRNA及其蛋白的表达明显减少(P<0.01)s,iRNA-2组细胞体外增殖能力减弱(P<0.05)。结论 RNAi技术可明显抑制Namalwa细胞VEGF的表达及细胞的体外增殖。 Purpose To explore the effect of RNA interference mediated vascular endothelial growth factor (VEGF) gene silencing on biological behavior of Namalwa cells. Methods Three specific siRNAs targeting to VEGF were synthesized and transfected into B cell malignant lymphoma Namalwa cells. After dssiRNA was transfected into Namalwa cells with Lipofectamine, the proliferative ability of Namalwa cells was evaluated by MTY migration assay. The expression of VEGF mRNA and protein level was analyzed by RT-PCR and Western blot technology, respectively. Results Only siRNA-2 group have statistical significance ( P 〈 0. 01 ), it effectively inhibited the proliferation of Namalwa cells ( P 〈 0. 05 ), and decreased the expression of VEGF on both mRNA and protein level. Conclusions The siRNA targeting human VEGF gene can reduce VEGF expression, inhibit cellular proliferation and induce apoptosis in Namalwa ceils in vitro.
出处 《临床与实验病理学杂志》 CAS CSCD 北大核心 2012年第1期38-41,共4页 Chinese Journal of Clinical and Experimental Pathology
基金 国家自然科学资金地区科学基金(30960122)
关键词 淋巴瘤 RNA干扰 Namalwa细胞 VEGF 基因治疗 lymphoma RNAi Namalwa cell VEGF gene therapy
  • 相关文献

参考文献11

  • 1van Krieken J H.New developments in the pathology of malignant lymphoma:a review of the literature published from May to July 2008[J].J Hematop,2008,1(2):145-60.
  • 2Podar K,Anderson K C.The pathophysiologic role of VEGF in hematologic malignancies:therapeutic implications[J].Blood,2005,105(4):1383-95.
  • 3Wang X,Cao W,Mo M,et al.VEGF and cortactin expression are independent predictors of tumor recurrence following curative resection of gastric cancer[J].J Surg Oncol,2010,102(4):325-30.
  • 4Aldner M J,Wirtz S,Jefremow A,et al.VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer[J].J Exp Med,2010,22(207):2855-68.
  • 5Botelho F,Pina F,Lunet N.VEGF and prostatic cancer:a systematic review[J].Eur J Cancer Prev,2010,19(5):385-92.
  • 6Trinh X B,Tjalma W A,Vermeulen1 P B,et al.The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer[J].Br J Cancer,2009,100(6):971-78.
  • 7Jrgensen J M,Srensen F B,Bendix K,et al.Expression level,tissue distribution pattern,and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1,KDR,and Flt-4[J].Leuk Lymphoma,2009,50(10):1647-60.
  • 8白晓川,郭宏伟.沙利度胺治疗复发难治性血液系统肿瘤14例临床观察[J].宁夏医学院学报,2006,28(2):138-139. 被引量:4
  • 9Lin M L,Lu Y C,Chung J G,et al.Down-regμlation of MMP-2 through the p38 MAPK-NF-κB-dependent pathway by aloe-emodin leads to inhibition of nasopharyngeal carcinoma cell invasion[J].Mol Carcinog,2010,49(9):783-97.
  • 10Tai W,Qin B,Cheng K.Inhibition of breast cancer cell growth and invasiveness by dual silencing of HER-2 and VEGF[J].Mol Pharm,2010,7(2):543-56.

二级参考文献6

  • 1Bertolini F,Mancuso P,Gobbi A,et al.The thin red line:angiogenesis in nomal and malignant hematopoiesis[J].Exp Hematol,2000,28:993-1000.
  • 2Mangi MH,Newland AC.Angiogenesis and angiogenic mediators in heamatological malignancies[J].Br J Haematol,2000,111:43-51.
  • 3Singhal S,Mehta J,Desikan R,et al.Antitumor activity of thalidomide inrefractory multiple myeloma[J].N Engl J Med,1999,341:1565-1571.
  • 4Hideshima T,Chauhan D,Shima Y,et al.Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy[J].Blood,2000,96:2943-2950.
  • 5原现华.反应停治疗浆细胞白血病一例[J].中华血液学杂志,2002,23(6):335-335. 被引量:2
  • 6王明林,刘曰芬,李英刚,吴洪光.酞咪哌啶酮治疗多发性骨髓瘤疗效与机制[J].中华血液学杂志,2002,23(10):514-516. 被引量:16

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部